Rosetta Signs Marketing Deal for Mesothelioma Test with Tort Claims Administration Firm

The test will be promoted as a means of determining whether plaintiffs in asbestos litigation have lung cancer or mesothelioma.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.